MOTS-C 40 MG
$120.00
This compound is a synthetic peptide analog derived from a mitochondrial open reading frame sequence, composed of sixteen amino acids arranged to support molecular stability and analytical reproducibility in vitro. It is structurally optimized for laboratory studies investigating mitochondrial signaling, peptide folding behavior, and energy-regulating pathways under controlled experimental conditions.
Add $100.00 to cart and get free shipping!
This compound is a synthetic peptide analog derived from a mitochondrial open reading frame sequence, composed of sixteen amino acids arranged to support molecular stability and analytical reproducibility in vitro. It is structurally optimized for laboratory studies investigating mitochondrial signaling, peptide folding behavior, and energy-regulating pathways under controlled experimental conditions.
The peptide is provided in lyophilized form for biochemical and cellular assay applications, offering researchers a reliable model for exploring mitochondrial-derived peptide activity and sequence–function interactions.
For Research Use Only (RUO). Not for human or veterinary use, or for medical, diagnostic, or therapeutic purposes.
MAECENAS IACULIS
Vestibulum curae torquent diam diam commodo parturient penatibus nunc dui adipiscing convallis bulum parturient suspendisse parturient a.Parturient in parturient scelerisque nibh lectus quam a natoque adipiscing a vestibulum hendrerit et pharetra fames nunc natoque dui.
ADIPISCING CONVALLIS BULUM
- Vestibulum penatibus nunc dui adipiscing convallis bulum parturient suspendisse.
- Abitur parturient praesent lectus quam a natoque adipiscing a vestibulum hendre.
- Diam parturient dictumst parturient scelerisque nibh lectus.
Scelerisque adipiscing bibendum sem vestibulum et in a a a purus lectus faucibus lobortis tincidunt purus lectus nisl class eros.Condimentum a et ullamcorper dictumst mus et tristique elementum nam inceptos hac parturient scelerisque vestibulum amet elit ut volutpat.

Reviews
There are no reviews yet.